1-(2,5-difluorobenzoyl)-3-methylpiperazine, 95.0%, 5g

Ethyl 5-methoxy-2-methylbenzoate, 97.0%, 5g

5,7-DICHLORO-2-METHYL-2H-PYRAZOLO[4,3-D]PYRIMIDINE, 95.0%, 1g

(1H-INDAZOL-7-YL)BORONIC ACID PINACOL ESTER, 95%, 1g

2-(2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}ethoxy)acetic acid, 97.0%, 5g

3-Amino-2-(4-(trifluoromethyl)benzyl)propanoic acid, 97%, 500mg

(3-(Benzyloxy)-6-bromo-2-fluorophenyl)(methyl)sulfane, 98%, 5g

N-Cyclopropyl-1-(3-fluorophenyl)methanesulfonamide, 95.0%, 100mg

4-(Bromomethyl)-1-methoxy-2-nitrobenzene, 95.0%, 100mg

7-Fluoro-1H-indazol-6-amine, 98%, 250mg

4-Bromo-3-methylpyrazole>98.0%(GC)5g

Plan PLPH S40x/0.65 phase contrast objective

2,2,4,4,6,8,8-Heptamethylnonane>97.0%(GC)500mL